II. Indications
- See NSAID
- FDA approved indications
- Rheumatoid Arthritis
- Osteoarthritis
- Mild to moderate pain
- Primary Dysmenorrhea
- Off-Label (Non-FDA approved) Indications
III. Contraindications
- See NSAID
IV. Mechanism
V. Medications
- Ketoprofen (Orudis) Immediate Release Capsules: 25 mg, 50 mg, 75 mg
- Ketoprofen (Orudis) Extended Release Capsules: 200 mg
VI. Dosing: Adult
- Immediate Release
- Arthritis (RA, OA): 75 mg orally three times daily (or 50 mg orally every 6 hours)
- Mild to moderate pain (including Dysmenorrhea): 25 to 50 mg orally every 6 to 8 hours
- Extended-Release
- Arthritis (RA, OA): 200 mg orally daily
VII. Dosing: Child
-
Juvenile Rheumatoid Arthritis (not FDA approved)
- Start 100 to 200 mg/m2/day in divided doses 3 to 4 times daily
- Maximum: 320 mg/day
VIII. Adverse Effects
- See NSAID
IX. Safety
X. Efficacy
- Ketoprofen 25 mg comparable to Ibuprofen 400 mg
- Ketoprofen 50 mg more potent than Tylenol #3
XI. Resources
- Ketoprofen Immediate Release (DailyMed)
- Ketoprofen Extended Release (DailyMed)
XII. References
- Hamilton (2020) Tarascon Pocket Pharmacopoeia